Exponent, Inc. (EXPO)
NEUTRAL基本面
65
价格
$69.78
市值
$3.39B
第一部分 · 这家公司值多少
概览
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
资产负债表与流动性
营收
$632M
最近12个月(截至2026/7/3)
净利润
$112M
最近12个月(截至2026/7/3)
自由现金流
$122M
股东权益合计
$390M
负债合计
$387M
流动比率
1.98
利息覆盖率
-
债务/EBITDA
0.62
每股收益
营收与净利润
自由现金流
收入构成
历史财务表
利润率变化
债务变化
债务负担有多重
增长一览表
增长 — 营业收入
公允价值估算
公允价值
$63.65
当前价格
$69.78
安全边际
-9.6%
公允价值区间
$45.42 - $81.89
估算方法
估值指标
市盈率(P/E)
31.88
ROE
27.2%
市净率(P/B)
11.66
P/FCF
31.00
毛利率
-
ROIC
20.4%
盈利能力雷达图
Value Creation (Economic Moat)
ROIC
20.4%
WACC
8.1%
ROIC − WACC
+12.3 pp
ROIC exceeds the cost of capital — the company is creating value for shareholders.
基本面分析标准
通过(18)
- EPS shows upward trend
- Price CAGR 8.82%
- ROIC 20.4%
- Debt/Equity ratio
- Operating Margin 20.2%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- Low reliance on intangibles
- ROE 27.9%
- Revenue Growth 5Y 7.8%
- Analyst Consensus 80% Buy
- Earnings Surprise avg 4.3%
- Earnings Quality (OCF/NI) 1.06
- Share Dilution -0.9%
- Piotroski F-Score 5/9
未通过(7)
- EPS CAGR 2.16%
- P/FCF 31.00
- P/B Ratio 11.66
- Price below Graham Number
- DCF valuation (Overvalued)
- PEG Ratio 4.90
- Net Margin Trend 17.7% vs 18.3%
不可用(3)
- Gross Margin NaN%
- Dividend Payout NaN%
- Interest Coverage
Piotroski F-评分
信号混杂:部分领域需关注
盈利质量
高质量:盈利有现金流支撑
股权稀释
正在回购股份,对股东友好
公司治理
管理团队
| 姓名 | 职位 | 年龄 |
|---|---|---|
| Dr. Catherine Ford Corrigan P.E., Ph.D. | CEO & Director | 56 |
| Mr. Richard L. Schlenker Jr. | Executive VP, Corporate Secretary & Director | 59 |
| Dr. Maureen T. F. Reitman F.S.P.E., P.E., Sc.D. | Group Vice President | 56 |
| Dr. Joseph Rakow Ph.D. | Group Vice President | 48 |
| Dr. Joseph Sala Ph.D. | Group Vice President | 48 |
| Dr. John D. Pye P.E., Ph.D. | President | 54 |
| Dr. Bernard Ross P.E., Ph.D. | Co-Founder & Principal Engineer | - |
| Mr. Eric R. Anderson | Chief Financial Officer | 50 |
| Ms. Gina Flynn | VP of Legal & General Counsel | - |
| Mr. Brian Kundert | Chief Human Resources Officer | 50 |
审计风险
9
董事会风险
2
薪酬风险
4
股东权利风险
2
第二部分 · 价格与买入时机
这一部分不判断公司是否值得拥有:它帮助你在基本面说服你之后,选择何时买入。包含:技术分析、潜力、历史回撤、Gamma 敞口。
Latest News
Recent headlines for EXPO, sourced from Markets Gazette.